Raffles Medical Group Ltd (RAFLF)
OTHER OTC:RAFLF
RAFLF Stock Chart & Stats
$0.80
$0.02(2.79%)
At close: 4:00 PM EST
$0.80
$0.02(2.79%)
Day’s Range― - ―
52-Week Range$0.69 - $0.87
Previous CloseN/A
Volume1.00K
Average Volume (3M)0.00
Market Cap
$1.51B
Enterprise Value$1.64B
Total Cash (Recent Filing)$334.18M
Total Debt (Recent Filing)$83.83M
Price to Earnings (P/E)26.7
Beta0.07
Next Earnings
Aug 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.11%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,884,544,900
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.95
Price to Book (P/B)1.78
Price to Sales (P/S)2.47
P/FCF Ratio19.23
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue2.14
Enterprise Value/Gross Profit4.70
Enterprise Value/Ebitda13.96
Forecast
1Y Price Target
$0.92Price Target Upside15.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.03
Revenue Forecast (FY)$623.18M
Bulls Say, Bears Say
Bulls Say
Capital Return ProgramRevised capital return plans that include higher dividend payouts and a planned share buyback program should provide direct support to the share price and investor sentiment.
China Hospital TurnaroundLosses at China hospitals are projected to narrow as partnerships with teaching hospitals boost referrals and converting health screenings into treatments raises utilization and fixed cost absorption.
Revenue Mix ImprovementHospital revenue growth is supported by higher patient volumes, larger average bills, and improved operational efficiency, which can lift top line and margins.
Bears Say
Insurance Margin SensitivityInsurance profitability is sensitive to medical cost trends and an unfavorable claims ratio could materially harm underwriting results and overall margins.
Insurer Pricing PressurePrice pressure from insurers and competition from new government hospitals constrains the ability to raise patient bills and limits revenue per case.
Singapore Demand WeaknessSluggish patient volumes in Singapore curb revenue growth and reduce the potential to achieve greater fixed cost absorption in the domestic business.
Raffles Medical Group News
RAFLF FAQ
What was Raffles Medical Group Ltd’s price range in the past 12 months?
Raffles Medical Group Ltd lowest stock price was $0.69 and its highest was $0.87 in the past 12 months.
What is Raffles Medical Group Ltd’s market cap?
Raffles Medical Group Ltd’s market cap is $1.51B.
When is Raffles Medical Group Ltd’s upcoming earnings report date?
Raffles Medical Group Ltd’s upcoming earnings report date is Aug 03, 2026 which is in 110 days.
How were Raffles Medical Group Ltd’s earnings last quarter?
Raffles Medical Group Ltd released its earnings results on Feb 22, 2026. The company reported $0.017 earnings per share for the quarter, beating the consensus estimate of N/A by $0.017.
Is Raffles Medical Group Ltd overvalued?
According to Wall Street analysts Raffles Medical Group Ltd’s price is currently Undervalued.
Does Raffles Medical Group Ltd pay dividends?
Raffles Medical Group Ltd pays a Annually dividend of $0.019 which represents an annual dividend yield of 3.11%. See more information on Raffles Medical Group Ltd dividends here
What is Raffles Medical Group Ltd’s EPS estimate?
Raffles Medical Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Raffles Medical Group Ltd have?
Raffles Medical Group Ltd has 1,884,544,900 shares outstanding.
What happened to Raffles Medical Group Ltd’s price movement after its last earnings report?
Raffles Medical Group Ltd reported an EPS of $0.017 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.151%.
Which hedge fund is a major shareholder of Raffles Medical Group Ltd?
Currently, no hedge funds are holding shares in RAFLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Raffles Medical Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$0.92 (15.00% Upside)
$0.92 (15.00% Upside)
Insider Transactions
Bought Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.09%
12-Months-Change
Fundamentals
Return on Equity
6.15%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
Raffles Medical Group Ltd
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore.
RAFLF Stock 12 Month Forecast
Average Price Target
$0.92
▲(15.00% Upside)
Technical Analysis
Thomson Medical Group Ltd.
―
Aoxin Q&M Dental Group Ltd.
―
ISEC Healthcare Ltd
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―
Ownership Overview
58.35% Insiders
1.66% Mutual Funds
0.04% Other Institutional Investors
38.23% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---